Difficulties in establishing a causal link between chemical exposures and cancer cannot be overcome by court assessments.

Human & Experimental Toxicology
T A Dragani

Abstract

Scientific data are often used in lawsuits to prove, or dismiss, causation by a claimed factor of a claimed disease. Recent media reports of million-dollar compensations awarded to some cancer patients who had been exposed to certain chemical substances motivated me to examine how solid the causal links really were. Here, I discuss the limitations of epidemiological research on cancer causation and highlight how new knowledge of cancer genetics makes it unrealistic to expect that cancer causation can be clearly demonstrated. I then present two exposure-cancer cases, namely talcum powder-ovarian cancer and glyphosate-non-Hodgkin lymphoma, that led to civil lawsuits decided, in the United States, in favor of the claimants. Both these cancers have several risk factors, among which the claimed exposure presents only a minor, if any, increased risk. Through these cases, I explain why the use of epidemiological data is inappropriate to define causal associations in complex diseases like cancer. I close by suggesting a fairer approach, called proportional liability, to resolving future cancer litigation cases.

References

Jun 1, 1991·Theoretical Medicine·P Vineis
Jun 1, 1981·Journal of the National Cancer Institute·S H Moolgavkar, A G Knudson
Oct 1, 1994·Environmental Health Perspectives·A TossavainenP J Karhunen
Mar 1, 1996·Journal of Clinical Pathology·D S James, A D Bull
May 1, 1996·American Journal of Industrial Medicine·D S HellerS Gerber
Jul 21, 2005·American Journal of Public Health·Kenneth J Rothman, Sander Greenland
Apr 8, 2006·The Lancet Oncology·Robertv BaanUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
May 27, 2006·Emerging Themes in Epidemiology·Carl V Phillips, Karen J Goodman
Jun 27, 2008·Southern Medical Journal·Anthony J Viera
May 7, 2009·The Lancet Oncology·Kurt StraifUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Jul 20, 2010·Nature Genetics·Lucia CondeChristine F Skibola
Oct 19, 2010·Cancer Epidemiology·Robert R GermanUNKNOWN Accuracy of Cancer Mortality Study Group
Feb 11, 2011·The Journal of Investigative Dermatology·Vincent PiguetKathleen Green
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 26, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alison ReidArthur W Musk
Jun 7, 2011·Environmental Health Perspectives·M Constanza CamargoPhilip J Landrigan
Jul 15, 2011·Cancer Causes & Control : CCC·Eleanor V KaneEve Roman
Feb 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I TramacereE Negri
Jul 28, 2012·Lancet·Kate R ShanklandBarry W Hancock
Sep 15, 2012·Genome Research·Jeong-Sun SeoYoung Tae Kim
Oct 31, 2012·Lancet·Kirstin PirieUNKNOWN Million Women Study Collaborators
Jun 8, 2013·Obstetrics and Gynecology·Laura J HavrileskyEvan R Myers
Jun 14, 2013·Cancer Prevention Research·Kathryn L TerryUNKNOWN Ovarian Cancer Association Consortium
Sep 28, 2013·American Journal of Epidemiology·Alfredo Morabia
Feb 21, 2014·BMC Medical Genomics·Peilin JiaZhongming Zhao
Sep 10, 2014·International Journal of Cancer. Journal International Du Cancer·Antonella GalvanTommaso A Dragani
Feb 26, 2015·American Journal of Epidemiology·Sophia S WangKarin E Smedby
Sep 5, 2015·Environmental Health Perspectives·Andrea 't MannetjeAnne Kricker
Sep 26, 2015·Blood·James R Cerhan, Susan L Slager
Jan 6, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Carlo La Vecchia
Jan 24, 2016·International Journal of Epidemiology·Jan P VandenbrouckeNeil Pearce

❮ Previous
Next ❯

Software Mentioned

PRISMA

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Indian Medical Gazette
J Ellis Barker
The Hospital and Health Review
J Ellis Barker
British Medical Journal
G W Nicholson
© 2021 Meta ULC. All rights reserved